Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00323167 · ClinicalTrials.gov registry record
Rare Genetic Disorders of the Breathing Airways
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 367
- Enrollment target
NCT00323167: Completed study, sponsored by University of North Carolina, Chapel Hill.
NCT00323167 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 367 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00323167 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 367 participants
- Enrollment target
Study Summary
Mucociliary clearance, in which mucus secretions are cleared from the breathing airways, is the primary defense mechanism for the lungs. Inhaled particles, including microbes that can cause infections, are normally entrapped in mucus on the airway surfaces and then cleared out by the coordinated action of tiny hair-like structures called cilia. Individuals with primary ciliary dyskinesia, variant cystic fibrosis, and pseudohypoaldosteronism have defective mucociliary clearance. The purpose of this study is to collect clinical and genetic information about these three airway diseases to improve current diagnostic procedures.
Primary Outcome
Not applicable. This is not an interventional study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2006-05 |
| Est. Completion | 2012-10 |
What the finished NCT00323167 record still lists
NCT00323167 is an observational study that tracks outcomes without assigning an intervention. The registered 367 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00323167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00323167 about?
NCT00323167 is a clinical study titled "Rare Genetic Disorders of the Breathing Airways". Mucociliary clearance, in which mucus secretions are cleared from the breathing airways, is the primary defense mechanism for the lungs. Inhaled particles, including microbes that can cause infections, are normally entrapped in mucus on the airway surfaces and then cleared out by the coordinated act...
What is the current status of trial NCT00323167?
This trial is currently completed. The enrollment target is 367 participants. The study started on 2006-05. Estimated completion is 2012-10.
Who is sponsoring clinical trial NCT00323167?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia